Table: begin end state 1 37 cytoplasmic 38 59 transmembrane 60 67 non-cytoplasmic 68 92 transmembrane 93 99 cytoplasmic 100 121 transmembrane 122 124 non-cytoplasmic 125 148 transmembrane 149 168 cytoplasmic 169 189 transmembrane 190 200 non-cytoplasmic 201 220 transmembrane 221 249 cytoplasmic 250 268 transmembrane 269 286 non-cytoplasmic 287 309 transmembrane 310 316 cytoplasmic 317 336 transmembrane 337 342 non-cytoplasmic 343 365 transmembrane 366 375 cytoplasmic 376 397 transmembrane 398 410 non-cytoplasmic 411 429 transmembrane 430 461 cytoplasmic
Input: >Pf1N1B4_5606 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_5606 VNNMSASITDAKDHAAETAPMKAPNRVKAIMGACSGNLVEWYDFFIYAYTAIYFAASFFP KGDTTSQLLATAGVFAVGFFMRPLGGWIFGWIADTRGRKVSMIISVFMMCAGSLLIAVMP TYATIGVAAPILLVVARLIQGLSVGAEYGTGATYISEIATPGRRCFYGSFQYFTIIAGQL LALMTVVILQQTLTGEELREWGWRIPFFIGALSSIVVVYLRRAMHETATKKDMNRKDAGS LRGMFKHKRAVALVVAFTIGGSLYFYTFTTYMQKFLVISAGFSPETVSFIMTAALVGFMF CQPLFGLLADRIGIKAHMLMFSGLAMLLVIPLLYSLQSVSSPFTAFLLVFGGLAIASLYT PIAGIVKAELFPPAVRALGVGFPYAVGNAAFGGTAEYVALSLRSQGVEAYFFFYVAAVVT ITFIAAMLMPNLSRYGYISGSGEIEERTGLKGCSKPSAARV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server